Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 9/2016

01-09-2016 | Original Article

Agreement between personally generated areas of quality of life concern and standard outcome measures in people with advanced cancer

Authors: Ala’ S Aburub, B. Gagnon, A. M. Rodríguez, Nancy E. Mayo

Published in: Supportive Care in Cancer | Issue 9/2016

Login to get access

Abstract

Purpose

People with advanced cancer experience different sequelae which have unique effects on quality of life (QOL). The patient-generated index (PGI) is a personalized measure that allows patients to nominate, rate, and value areas that have the most impact on QOL. Fatigue, pain, and aspects of physical function are among the top 10 areas with QOL impact. An area of validation that is lacking for the PGI is the extent to which spontaneously nominated areas of QOL that patients are concerned with, agree with ratings obtained from standard patient reported outcomes (PROs).

Methods

Data from 192 patients were used to compare ratings on fatigue, pain, and physical function obtained from PGI to those from standard outcome measures.

Results

Within one severity rating, agreement ranged from 32.1 to 76.9 % within the fatigue domain, 34.2 to 95.24 % for pain, and between 84.2 and 94.7 % for physical function. Of the 10 items where the PGI had the highest agreement, 7 came from the RAND-36. At the domain level, people nominating an area scored in the more impaired range on standard measures than people who did not.

Conclusion

PGI gives comparable information as do standard measures.

Implications for cancer

PGI provides important information to guide clinical care of the patient and also produces a legitimate total score suitable for research.
Appendix
Available only for authorised users
Literature
1.
Smith T et al. (2007) The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer 109(1):1–12CrossRefPubMed
2.
Lehmann JF et al. (1978) Cancer rehabilitation: assessment of need, development, and evaluation of a model of care. Arch Phys Med Rehabil 59(9):410–419
3.
Ness KK et al. (2006) Physical performance limitations and participation restrictions among cancer survivors: a population-based study. Ann Epidemiol 16(3):197–205CrossRefPubMed
4.
Zucca A et al. (2015) Medical oncology patients: are they offered help and does it provide relief? J Pain Symptom Manag 50(4):436–444CrossRef
5.
Aburub AS et al. (2016) Using a personalized measure (Patient Generated Index (PGI)) to identify what matters to people with cancer. Support Care Cancer 24(1):437–445CrossRefPubMed
6.
Donnelly S, Walsh D (1995) The symptoms of advanced cancer. Semin Oncol 22(2 Suppl 3):67–72PubMed
7.
Morrow GR et al. (2005) Management of cancer-related fatigue. Cancer Investig 23(3):229–239CrossRef
8.
Mayo NE et al. (2014) Pedometer-facilitated walking intervention shows promising effectiveness for reducing cancer fatigue: a pilot randomized trial. Clin Rehabil 28(12):1198–1209CrossRefPubMed
9.
Cramp, F. and J. Daniel, Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev, 2008(2): p. Cd006145.
10.
Cancer-related fatigue. (2003) Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 1(3):308–331
11.
Network, N.C.C., Clinical practice guidelines in oncology—cancer-related fatigue., 2009. V2.2009.
12.
Di Maio M et al. (2004) Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer 90(12):2288–2296PubMedPubMedCentral
13.
Stromgren AS et al. (2004) Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care. J Pain Symptom Manag 27(2):104–113CrossRef
14.
Knudsen AK et al. (2009) Classification of pain in cancer patients—a systematic literature review. Palliat Med 23(4):295–308CrossRefPubMed
15.
Kocoglu H et al. (2002) Cancer pain, pathophysiology, characteristics and syndromes. Eur J Gynaecol Oncol 23(6):527–532PubMed
16.
Lunney JR et al. (2003) Patterns of functional decline at the end of life. JAMA 289(18):2387–2392CrossRefPubMed
17.
Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132(11 Suppl):3456S–3464SPubMed
18.
McMichael AJ (2008) Food, nutrition, physical activity and cancer prevention. Authoritative report from World Cancer Research Fund provides global update. Public Health Nutr 11(7):762–763CrossRefPubMed
19.
20.
Midtgaard J et al. (2015) Cancer survivors’ experience of exercise-based cancer rehabilitation—a meta-synthesis of qualitative research. Acta Oncol 54(5):609–617CrossRefPubMed
21.
Salakari MR et al. (2015) Effects of rehabilitation among patients with advances cancer: a systematic review. Acta Oncol 54(5):618–628CrossRefPubMed
22.
Weis J, Giesler JM (2014) Rehabilitation for cancer patients. Recent Results Cancer Res 197:87–101CrossRefPubMed
23.
Dimoska A et al. (2008) Can a “prompt list” empower cancer patients to ask relevant questions? Cancer 113(2):225–237CrossRefPubMed
24.
Group EQOL (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef
25.
Gudex C et al. (1996) Health state valuations from the general public using the visual analogue scale. Qual Life Res 5(6):521–531CrossRefPubMed
26.
Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25(24):3130–3139
27.
Aaronson NK et al. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed
28.
Cella DF et al. (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
29.
Ribaudo JM et al. (2000) Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9(10):1137–1146CrossRefPubMed
30.
Cohen SR, Mount BM (2000) Living with cancer: “good” days and “bad” days–what produces them? Can the McGill quality of life questionnaire distinguish between them? Cancer 89(8):1854–1865CrossRefPubMed
31.
Cohen SR et al. (1997) Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 11(1):3–20CrossRefPubMed
32.
Cohen SR et al. (1995) The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 9(3):207–219CrossRefPubMed
33.
Bruera E et al. (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed
34.
Ruta DA et al. (1994) A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care 32(11):1109–1126CrossRefPubMed
35.
Hickey AM et al. (1996) A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 313(7048):29–33CrossRefPubMedPubMedCentral
36.
Joyce CR et al. (2003) A theory-based method for the evaluation of individual quality of life: the SEIQoL. Qual Life Res 12(3):275–280CrossRefPubMed
37.
Ruta DA, Garratt AM, Russell IT (1999) Patient centred assessment of quality of life for patients with four common conditions. Qual Health Care 8(1):22–29CrossRefPubMedPubMedCentral
38.
Phantipa Sakthong P (2014) Win Winit-Watjana, MD2, Kobkan Choopan, MSc (Clin Pharm)3, Usefulness of Patient-Generated Index for HIV to measure individual quality of life: a study from Thailand. V A L U E I N H E A L T H R E G I O N A L I S S U E S 3:101–107
39.
Martin F et al. (2007) Twelve years’ experience with the Patient Generated Index (PGI) of quality of life: a graded structured review. Qual Life Res 16(4):705–715CrossRefPubMed
40.
Machhin, P.M.F.a.D., Qulaity of life, second edition: the assessment, analysis and interpretation of patients reported outcomes. 2007.
41.
Rodriguez AM, Mayo NE, Gagnon B (2013) Independent contributors to overall quality of life in people with advanced cancer. Br J Cancer 108(9):1790–1800CrossRefPubMed
42.
Bohannon RW, Wang YC, Gershon RC (2015) Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness. Arch Phys Med Rehabil 96(3):472–477CrossRefPubMed
43.
Mock V et al. (2007) Cancer-related fatigue. clinical practice guidelines in oncology. J Natl Compr Cancer Netw 5(10):1054–1078
44.
Tavernier SS, Totten AM, Beck SL (2011) Assessing content validity of the patient generated index using cognitive interviews. Qual Health Res 21(12):1729–1738CrossRefPubMed
Metadata
Title
Agreement between personally generated areas of quality of life concern and standard outcome measures in people with advanced cancer
Authors
Ala’ S Aburub
B. Gagnon
A. M. Rodríguez
Nancy E. Mayo
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3204-4

Other articles of this Issue 9/2016

Supportive Care in Cancer 9/2016 Go to the issue

Original Article

Fatigue in adolescent and adult survivors of non-CNS childhood cancer: a report from project REACH

Original Article

EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections

Original Article

Randomized pilot trial of yoga versus strengthening exercises in breast cancer survivors with cancer-related fatigue

Original Article

Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis

Original Article

Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS® laser therapy in breast cancer patients

Original Article

Cancer-related fatigue: appraising evidence-based guidelines for screening, assessment and management
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits